(NASDAQ: TIL) Instil Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.19%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.9%.
Instil Bio's earnings in 2025 is -$84,510,000.On average, 1 Wall Street analyst forecast TIL's earnings for 2025 to be -$77,970,770, with the lowest TIL earnings forecast at -$77,970,770, and the highest TIL earnings forecast at -$77,970,770. On average, 1 Wall Street analyst forecast TIL's earnings for 2026 to be -$59,473,808, with the lowest TIL earnings forecast at -$59,473,808, and the highest TIL earnings forecast at -$59,473,808.
In 2027, TIL is forecast to generate -$53,870,714 in earnings, with the lowest earnings forecast at -$53,870,714 and the highest earnings forecast at -$53,870,714.